Medicover AB (publ) (ST:MCOV-B) — Market Cap & Net Worth
Market Cap & Net Worth: Medicover AB (publ) (MCOV-B)
Medicover AB (publ) (ST:MCOV-B) has a market capitalization of $1.94 Billion (Skr18.05 Billion) as of September 16, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #6274 globally and #90 in its home market, demonstrating a 2.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicover AB (publ)'s stock price Skr242.50 by its total outstanding shares 74428717 (74.43 Million). Also see MCOV-B current and non-current assets for a full breakdown of the balance sheet.
Medicover AB (publ) Market Cap History: 2017 to 2026
Medicover AB (publ)'s market capitalization history from 2017 to 2026. Data shows growth from $503.35 Million to $1.94 Billion (15.11% CAGR). Also see Medicover AB (publ) (MCOV-B) cash flow conversion for how efficiently the company converts equity into cash flow.
Medicover AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medicover AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Medicover AB (publ) share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.74x
Medicover AB (publ)'s market cap is 0.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
92.09x
Medicover AB (publ)'s market cap is 92.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $503.35 Million | $580.20 Million | $18.70 Million | 0.87x | 26.92x |
| 2018 | $585.64 Million | $671.60 Million | $24.60 Million | 0.87x | 23.81x |
| 2019 | $867.68 Million | $844.40 Million | $22.50 Million | 1.03x | 38.56x |
| 2020 | $1.31 Billion | $997.80 Million | $25.80 Million | 1.31x | 50.79x |
| 2021 | $2.96 Billion | $1.38 Billion | $101.80 Million | 2.15x | 29.05x |
| 2022 | $1.12 Billion | $1.51 Billion | $11.80 Million | 0.74x | 94.69x |
| 2023 | $1.20 Billion | $1.75 Billion | $17.60 Million | 0.69x | 68.26x |
| 2024 | $1.54 Billion | $2.09 Billion | $16.70 Million | 0.74x | 92.09x |
Competitor Companies of MCOV-B by Market Capitalization
Companies near Medicover AB (publ) in the global market cap rankings as of September 16, 2026. Review Medicover AB (publ) tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Medicover AB (publ) by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
Medicover AB (publ) Historical Marketcap From 2017 to 2026
Between 2017 and today, Medicover AB (publ)'s market cap moved from $503.35 Million to $ 1.94 Billion, with a yearly change of 15.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr1.94 Billion | +9.98% |
| 2025 | Skr1.77 Billion | +14.84% |
| 2024 | Skr1.54 Billion | +28.01% |
| 2023 | Skr1.20 Billion | +7.52% |
| 2022 | Skr1.12 Billion | -62.21% |
| 2021 | Skr2.96 Billion | +125.68% |
| 2020 | Skr1.31 Billion | +51.01% |
| 2019 | Skr867.68 Million | +48.16% |
| 2018 | Skr585.64 Million | +16.35% |
| 2017 | Skr503.35 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Medicover AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.94 Billion USD |
| MoneyControl | $1.94 Billion USD |
| MarketWatch | $1.94 Billion USD |
| marketcap.company | $1.94 Billion USD |
| Reuters | $1.94 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more